Author:
Kerbusch T,Groenewegen G,Mathôt R A A,Herben V M M,ten Bokkel Huinink W W,Swart M,Ambaum B,Rosing H,Jansen S,Voest E E,Beijnen J H,Schellens J H M
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Bienvenu BJ, Soinet SL, Tong W, Aghajanianh C, Waltzman R, Peyton M, Pezzuli S, Spriggs D (2000) Phase I dose escalation study of topotecan and ifosfamide in patients with refractory non-haematological malignancies. Proc Am Assoc Cancer Res 41: 223 (abstract 871)
2. Boeckman AJ, Sheiner LW, Beal SL (1994) NONMEM Users Guide – Part V: Introductory Guide. San Francisco, USA: NONMEM Project Group, University of California
3. Cerny T, Küpfer A (1992) The enigma of ifosfamide encephalopathy. Ann Oncol 3: 679–681
4. Creemers GJ, Wanders J, Gamucci T, Vallentin S, Dirix LY, Schoffski P, Hudson I, Verweij J (1995) Topotecan in colorectal cancer: a phase II study of the EORTC early clinical trials group. Ann Oncol 6 (Suppl): 844–846
5. Gallo JM, Laub PB, Rowinsky EK, Grochow LB, Baker SD (2000) Population pharmacokinetic model for topotecan derived from phase I clinical trials. J Clin Oncol 18: 2459–2467
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献